Full Text View
Tabular View
No Study Results Posted
Related Studies
Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
This study has been completed.
Study NCT00650208   Information provided by Mylan Pharmaceuticals

First Received on March 30, 2008.   Last Updated on March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Lamotrigine Tablets 25 mg
Lamictal® Tablets 25 mg
Additional drug interventions recognized in this trial
Lamotrigine
More general drug interventions related to this trial
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Mylan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services